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Abstract
Objectives (1) To determine the association between patellar tendon stiffness and the presence of patellar tendinopathy (PT). (2)
To evaluate the reliability of shear-wave elastography (SWE).
Methods Participants were consecutively enrolled between January 2017 and June 2019. PT was diagnosed clinically and confirmed
by either grayscale US or power Doppler US, or both. Controls had no history of anterior knee pain and no clinical signs of PT. Patellar
tendon stiffness (kilopascal, kPa) was assessed using SWE. Logistic regression was used to estimate adjusted odds ratios (ORs) and
95% confidence intervals (CIs). Reliability analyses included coefficients-of-variation (CV), coefficients-of-repeatability (CR),
intraclass correlation coefficient (ICC) for intraobserver and interobserver reliability, and Bland-Altman analysis.
Results In total, 76 participants with PT (58 men, mean age 24.4 ± 3.8 years) and 35 asymptomatic controls (16 men, mean age
21.5 ± 3.8 years) were included. Univariate analyses (OR 1.094, 95% CI 1.061–1.128, p < .001) and adjusted multivariate
analyses (OR 1.294, 95% CI 1.044–1.605, p = .018) showed that athletes with PT had significantly increased patellar tendon
stiffness. ICC for intraobserver reliability was 0.95 (95% CI 0.92–0.97), CR (CV) 12 kPa (10%) and 0.79 (95% CI 0.65–0.88),
CR (CV) 18 kPa (21%) for interobserver reliability. Mean differences from Bland-Altman analysis were 5.6 kPa (95% CI 3.1–
8.1, p < .001) for intraobserver reliability and 4.6 kPa (95% CI 1.9–7.2, p < .001) for interobserver reliability.
Conclusions PT is associated with significantly higher patellar tendon stiffness. SWE measurements demonstrate excellent
intraobserver reliability and good interobserver reliability. Therefore, SWE is a promising tool to implement in longitudinal
studies and future studies should evaluate its prognostic value and utility as a monitoring tool in athletes with PT.
Key Points
• Patellar tendon stiffness measured with shear-wave elastography (SWE) is higher in athletes with patellar tendinopathy than in
healthy controls, also after adjusting for potential confounders.
• Excellent intraobserver reliability and good interobserver reliability were found for the quantitative assessment of patellar
tendon stiffness using SWE.
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Introduction
Patellar tendinopathy (PT) is an overuse injury of the patellar
tendon resulting in pain, decreased exercise tolerance, and
impaired function [1]. PT is highly prevalent in jumping ath-
letes, with reported rates of 45% for elite volleyball players
and 32% for elite basketball players [2]. There is consensus
that PT is a clinical diagnosis with focal load-related pain,
established by medical history taking and clinical examina-
tion. Currently, the applicability of ultrasound (US) is limited
to confirming the clinical diagnosis of PT by assessing mor-
phological changes [3]. Tendinopathy-related abnormalities
on US are tendon thickening with hypoechoic areas and/or
increased Doppler flow [4, 5]. These alterations are associated
with tendinopathy; however, they have also been reported in
up to 59% of asymptomatic athletes [6]. Therefore, changes in
tendon structure on grayscale US (GSUS) are considered a
risk factor for tendinopathy rather than indicative for PT or
tendon pain [7]. Alternative imaging techniques that better
reflect pain remain to be investigated as they could provide
attractive novel biomarkers to assess therapy response.
Shear-wave elastography (SWE) is an ultrasound-based im-
aging technique which evaluates viscoelastic properties, depicted
as color-coded images (elastogram) [8]. Accordingly, SWE of-
fers additional information to structural changes observed with
GSUS. SWE assesses tendon stiffness both qualitatively and
quantitatively by acquiring velocity measurements of directional
propagating shear-waves generated by focused ultrasound pulses
[9]. The assessment of patellar tendon stiffness using SWE could
potentially correlate better with experienced pain in athletes with
PT. Moreover, the superficial location of the patellar tendon fa-
cilitates implementation of SWE.
Musculoskeletal applications of SWE constitute a relative-
ly new area which has emerged from well-established appli-
cations in breast, liver, thyroid, and prostate imaging [10–13].
Additionally, SWE has already shown potential to discrimi-
nate between athletes with unilateral PT and asymptomatic
athletes [14]. However, recent studies reported conflicting
SWE outcomes in PT [15]. Consequently, the association be-
tween patellar tendon stiffness measured with SWE and the
presence of PT and the reliability of SWE are still largely
unknown.
The primary aim of this study was, therefore, to determine
the association between patellar tendon stiffness and the pres-
ence of PT in jumping athletes. The secondary aim was to
evaluate the reliability of the patellar tendon stiffness assess-
ment and image analysis using SWE.
Materials and methods
This case-control study in Erasmus MC University Medical
Center Rotterdam, The Netherlands, was approved by the
institutional review board. Participants provided written in-
formed consent prior to inclusion. We performed cross-
sectional analysis of baseline data from a prospective trial
investigating two different exercise programs for PT
(ClinicalTrials.gov, ID: NCT02938143).
Study participants
Participants were consecutively enrolled. National sports fed-
erations and regional healthcare providers facilitated recruit-
ment. Athletes performing sports involving frequent jumping
or cutting maneuvers were eligible. Potential subjects
underwent initial online screening to assess the location of
tenderness on a self-reported pain map [16]. The Victorian
Institute of Sports Assessment questionnaire for patellar ten-
dons (VISA-P) was administered to measure symptoms, func-
tion, and ability to play sports [17]. A VISA-P < 80was one of
the inclusion criteria for PT [18]. All eligibility criteria are
listed in Table 1.
Inclusion protocol
Jumping athletes with suspected PT and asymptomatic ath-
letes were invited to our hospital to confirm eligibility.
Clinical evaluation was performed by a sports physician
(R.V.) with 10 years’ experience, and athletes were regarded
positive for PT if tenderness at the inferior patellar pole or
patellar tendon could be reproduced on palpation and a
single-leg squat [19]. Provocation tests of the patellofemoral
joint were performed to exclude patellofemoral pain [20].
Subsequently, GSUS and power Doppler US (PDUS) were
performed to verify the clinical diagnosis. US criteria for PT
were presence of structural and/or hypoechoic changes and/or
tendon thickening (anterior-posterior diameter > 6 mm) and/or
the presence of intratendinous Doppler flow [21]. We defined
our reference standard for having PT as a clinical diagnosis
with affirmative findings on GSUS and/or PDUS. For athletes
with bilateral PT, the individual selected the most painful side.
Asymptomatic athletes who had a maximum VISA-P score
(100/100) and no history of anterior knee pain or diagnosis of
PT were used as controls (Table 1). GSUS and PDUS were
acquired, but findings were not an eligibility criterion in this
group. Weight and height measures were used to calculate
body mass index (kg/m2). Activity level was assessed using
the Cincinnati Sports Activity Scale (CSAS) [22].
Imaging methods
USwas performed by one trained examiner (S.B.: radiologist-
in-training with 5 years’ experience) using an ultrasound ma-
chine equipped with SWE (LOGIQ E9, GE Healthcare). A
linear 5–15-MHz transducer (ML6-15, GE Healthcare) was
used for GSUS and PDUS and a linear 3.1–10-MHz
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transducer (9L, GE Healthcare) for SWE. Ultrasound gel
(Sonogel Vertriebs GmbH) was used at room temperature
(21 °C).
Participants were examined in supine position with the
back rest of the examination table upright in 60° for patient
comfort and improved patellar tendon relaxation. GSUS was
performed with both knees in 30° flexion, supported by a
foam roll. PDUS and SWE were performed in passive exten-
sion of both knees. The standardized US acquisition protocol
included longitudinal and transverse GSUS of the patellar
tendon and transverse cine-loops for PDUS. The patellar ten-
don was designated as vascular if it demonstrated one or more
blood vessels in the posterior portion of the patellar tendon or
within the tendon. SWE was performed with mild pressure, in
the longitudinal plane with the inferior patellar pole just in the
field-of-view. Elastograms were generated in dual-screen
mode, displaying GSUS and the overlaying elastogram.
Three elastograms were acquired, of which one was randomly
selected for the first analysis directly after the image acquisi-
tion. A second analysis of all elastograms in PT athletes was
performed by the same examiner (S.B.) after the recruitment
of subjects had finished, blinded for the results of the first
analysis. The second analysis consisted of stiffness measure-
ments in all three elastograms acquired using the samemethod
as the first analysis. Patellar tendon stiffness was averaged for
the three elastograms and the relative variability of these mea-
surements was calculated. The maximum thickness of subcu-
taneous tissue overlying the proximal patellar tendon was
measured on a transverse GSUS image, at a standardized lo-
cation within 1 cm below the inferior patellar border. A subset
of controls was invited consecutively to be re-examined with
SWE at the same time point by an independent examiner
(A.V.) with 2 years’ experience, who also performed the anal-
yses of these collected images, blinded for the results of the
first examiner. Quantitative analysis of patellar tendon stiff-
ness was performed on the ultrasound machine, with maxi-
mum transparency of the elastograms to avoid subjective
placements of regions-of-interests (ROIs). A reference ruler
of 20 mm was set posterior to the patellar tendon, starting
5 mm distal to the inferior patellar pole. This guided
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Asymptomatic
athletes
Age 18–35 years Acute knee or patellar tendon injuries
Playing patellar tendon-loading sports for at least 3 times a week Prior knee surgery without full rehabilitation
No history of anterior knee pain or diagnosis of PT Known presence of inflammatory joint diseases
or familial hypercholesterolemia
VISA-P score 100/100 points Daily use of drugs with a putative effect on the patellar
tendon in the preceding 12 months (e.g.,
fluoroquinolones)
Local injection therapy with corticosteroids in the
preceding 12 months
Previous patellar tendon rupture
Patellar
tendinopathy
Age 18–35 years Acute knee or patellar tendon injuries
Playing patellar tendon-loading sports for at least 3 times a week Prior knee surgery without full rehabilitation
History of anterior knee pain located in the trajectory of the patellar
endon or its patellar or tibial insertion in association with training
and competition
Known presence of inflammatory joint diseases or
familial hypercholesterolemia
Tenderness on palpation in the corresponding painful area Daily use of drugs with a putative effect on the patellar
tendon in the preceding 12 months (e.g.,
fluoroquinolones)
Symptom duration of at least 2 weeks Local injection therapy with corticosteroids in the
preceding 12 months
VISA-P score < 80/100 points Previous patellar tendon rupture
On ultrasound, presence of structural and/or hypoechoic changes of
highly organized fiber bundles and/or tendon thickening
(anterior-posterior diameter > 6 mm) and/or the presence of
Doppler flow detected with PDUS.
Daily exercise therapy with a minimum duration of
4 weeks in total in the preceding 12 months
Contraindications for MRI
PT, patellar tendinopathy; VISA-P, Victorian Institute of Sports Assessment questionnaire for patellar tendons; PDUS, power Doppler ultrasound
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placement of circular ROIs and avoided inclusion of artifacts
from the patella (Fig. 2). ROIs were not fixed in size or num-
ber. Median tendon stiffness (kPa) was calculated for each
ROI and overall median stiffness including all ROIs. The sep-
arate ROIs were labeled “ROI1-ROI4” from proximal to distal
in the proximal patellar tendon.
Statistical analysis
SPSS software (version 25; IBM Corp.) was used. Normal
distribution was tested using Shapiro-Wilk’s test. Median
and interquartile range (IQR) were obtained for non-
normally distributed data. Between-group differences were
assessed with Student’s t test for normally distributed data
and Mann-Whitney U test for non-normally distributed data.
Analyses included the influence of tendon calcifications on
patellar tendon stiffness in specific ROIs. In athletes with uni-
lateral PT, we compared patellar tendon stiffness between the
symptomatic and the asymptomatic patellar tendon. Logistic
regression analysis was performed to calculate odds ratios
(ORs) and 95% confidence intervals (95% CIs). Univariate
(unadjusted) and multivariate models adjusted for potential
confounders, including age, sex, body mass index, and thick-
ness of subcutaneous tissue, were applied. Determinants with
p value < .10 were used in the multivariable model. Interaction
terms for age*stiffness and sex*stiffness were added, based on
findings in previous research [23, 24]. Multicollinearity was
tested using variance inflation factor (VIF), with an acceptable
maximum of 2.5. The relative variability of the three SWE
measurements was assessed using coefficient-of-variation
(CV) and coefficient-of-repeatability (CR). The intraobserver
reliability for the analyses of the different elastograms and
interobserver reliability for independent SWE acquisitions
and analyses were assessed using CV, CR, intraclass correla-
tion coefficient (ICC), and Bland-Altman analysis [25–27].
An ICC value reflected “poor” (less than 0.5), “moderate”
(between 0.5 and 0.75), “good” (between 0.75 and 0.9), and
“excellent” (greater than 0.90) [28]. P values < .05 were con-
sidered statistically significant.
Results
Study population
Participants were consecutively enrolled between January
2017 and June 2019. A total of 313 applications from poten-
tially eligible PT athletes and asymptomatic controls were
initially screened, of which 138 participants were invited to
our hospital to verify or exclude the diagnosis of PT. Finally,
111 participants remained eligible for inclusion (Fig. 1).
Clinical and demographic characteristics of the study popula-
tion are listed in Table 2. Participants with PT were
significantly older, had higher BMI, and consisted of more
men than asymptomatic controls. Athletes with PT (n = 76)
participated in volleyball (n = 26), soccer (n = 17), basketball
(n = 16), korfball (n = 8), track and field (n = 4), field hockey
(n = 3), and handball (n = 2) as primary sports. Asymptomatic
controls (n = 35) participated in basketball (n = 15), korfball
(n = 10), volleyball (n = 9), and track and field (n = 1). No
significant differences were found in activity levels between
athletes with PT and asymptomatic controls. In PT athletes,
the left patellar tendon was the primary site of symptoms in 41
participants (54%) and the right patellar tendon in 35 partici-
pants (46%). The diagnosis of PT was unilateral in 44 partic-
ipants (58%), of which 26 were left-sided. Median duration of
symptoms in PT athletes was 104 weeks (IQR, 43–
208 weeks).
GSUS and PDUS findings
The proximal patellar tendon was significantly thicker in PT
athletes (mean 8.4 ± 2.4 mm) than in asymptomatic controls
(mean 4.1 ± 0.9 mm) (p < .001). Hypoechoic changes were
seen in 89% of PT athletes and 26% of asymptomatic controls.
Screened online for eligibility (n= 313)
Excluded n=175
Reasons for patellar tendinopathy athletes:
• Withdrawal (n=53)
• No isolated anterior knee pain (n=40)
• Age <18 or >35 (n=25)
• No tendon-loading sports (n=18)
• VISA-P ≥ 80 (n=18)
• Exercise therapy for PT ≥ 3x/week (n=12)
• Open knee surgery (n=5)
Reasons for asymptomatic controls:
• History of PT (n=4)
Participants invited to our hospital (n=138)
Excluded n=27
Reasons for patellar tendinopathy athletes:
• Suspicion of patellofemoral pain (n=17)
• No clinical diagnosis of PT (n=2)
• US-confirmed bursitis (n=2)
• Withdrawal (n=3)
• VISA-P ≥ 80 (n=1)
Reasons for asymptomatic controls:
• VISA-P < 100 (n=2)
Eligible participants (n=111)
Fig. 1 Recruitment flowchart of PT athletes and asymptomatic controls
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Tendon calcifications were observed in 27% of PT athletes
and erosions of the inferior patellar border in 29%. Both were
absent in asymptomatic controls. Intratendinous Doppler flow
was present in 89% of PT athletes and 3% of asymptomatic
controls.
SWE findings
Stiffness of the proximal patellar tendon was significantly
higher in PT athletes (median 74.9 kPa, IQR [56.4–105.4])
than in asymptomatic athletes (median 35.6 kPa, IQR [29.9–
43.0]) (p < .001) (Fig. 2). In PT athletes, no significant differ-
ence in patellar tendon stiffness was found between primary
left-symptomatic athletes and primary right-symptomatic ath-
letes (p = .360). Only in ROI 1, patellar tendon stiffness was
significantly higher in PT with tendon calcifications than in
PT without calcifications (p = .017). In PT athletes without
tendon calcifications, symptomatic tendons were still signifi-
cantly stiffer than asymptomatic tendons in ROI 1, both on the
left (p = .043) and right (p = .005) side, but not in other ROIs.
This increased stiffness in ROI 1 was not observed in the
asymptomatic tendons (left p = .679 and right p = .396).
Variability of the SWE measurements in PT athletes
For the patellar tendon stiffness assessments in all ROIs, the
CVwas 5.3% (95%CI 4.0–6.3) and the CR was 6.6 kPa (IQR
3.6–12.1). For analysis in separate ROIs, the CV ranged from
10.8 to 11.8% and the CR ranged from 7.3 to 10.7 kPa.
Association between patellar tendon stiffness and PT
Patellar tendinopathy was associated with significantly
higher patellar tendon stiffness, both in univariate analy-
ses (OR 1.094, 95% CI 1.061–1.128, p < .001) and in
adjusted multivariate regression analyses (OR 1.294,
95% CI 1.044–1.605, p = .018). The odds ratios for pa-
tellar tendon stiffness are estimated for each kilopascal
(kPa). In univariate analysis, 7 determinants were associ-
ated with the presence of PT symptoms with a p value
< 0.10, and therefore included in the multivariate model
(Table 3). The variance inflation factors were well within
the acceptable limit (range VIF, 1.25–1.56).
Intraobserver reproducibility of SWE
The intraobserver reliability analysis (Table 4) revealed an
intraclass correlation coefficient (ICC) of 0.95 (95% CI
0.92–0.97) for the median patellar tendon stiffness using all
ROIs between analysis 1 (median stiffness 74.9 kPa [56.4–
105.4]) and analysis 2 (median stiffness 69.9 kPa [54.7–
100.3]). The coefficient-of-repeatability (CR) and
coefficient-of-variation (CV) were 11.9 kPa [5.1–24.9] and
10.3% (95% CI 7.9–12.2), respectively. For the separate
ROIs, the ICC ranged from 0.85 to 0.92 and CR (CV) from
13.3 to 20.2 kPa (15.1–19.2%). The mean difference from
Bland-Altman analysis (Fig. 3) was 5.6 kPa (95% CI 3.1–
8.1, p < .001) and limits of agreement were −15.8 kPa (lower
limit) and 26.9 kPa (upper limit).
Table 2 Baseline characteristics
of participants Characteristic Asymptomatic athletes (n = 35) Patellar tendinopathy (n = 76) p value
Mean age (year) 21.4 ± 3.8 24.4 ± 3.8 < .001
No. of men 18 (51) 58 (76) .003
Mean height (cm) 180.1 ± 10.3 184.7 ± 9.3 .02
Mean weight (kg) 71.0 ± 9.5 81.8 ± 12.3 < .001
Mean BMI (kg/m2) 21.9 ± 1.8 23.9 ± 2.9 < .001
Mean clinical score (VISA-P) 100 ± 0 55 ± 13 < .001
Sports activity scale (CSAS) .10
Level I (4 to 7 days/week)
100 8 (23) 17 (22)
95 0 (0) 0 (0)
90 0 (0) 0 (0)
Level II (1 to 3 days/week)
85 27 (77) 50 (66)
80 0 (0) 9 (12)
Data are means ± standard deviation except where they are numbers of participants and data in parentheses are
percentages. BMI, body mass index; VISA-P, Victorian Institute of Sports Assessment questionnaire for patellar
tendons; CSAS, Cincinnati Sports Activity Scale
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Asymptomatic athlete Patellar tendinopathy athlete legend
(A,D) Longitudinal grayscale ultrasound images of the proximal patellar tendon in an asymptomatic 19 year old 
male basketball player (A) and in a 21 year old male basketball player with patellar tendinopathy (D). (A) 
shows normal alignment of collagen bundles, whereas (D) shows disruption of the normal tendon architecture 
with hypoechoic areas separating collagen bundles.
(B,E) Elastograms depicted as an overlay on grayscale images where user settings defined red as stiff tissues and 
blue as soft tissues. Pronounced red areas (indicating increased stiffness) were typically observed in the 
proximal patellar tendon of participants with patellar tendinopathy (E), compared to predominantly light blue 
areas (representing intermediate elasticity) in asymptomatic athletes (B). Dark blue areas posterior to the 
patellar tendon correspond to the relative soft Hoffa’s fatpad. The small red area at the left border in both (B) 
and (E) corresponds to the inferior patellar border and was excluded for quantitative analysis.
(C,F) Multiple partially overlapping circular regions of interest were placed for quantitative analysis of tendon 
stiffness, covering the proximal 20 mm of the patellar tendon (referred by reference ruler), starting 5 mm 
distal to the inferior patellar pole. The median stiffness [interquartile range] of the proximal patellar tendon in 
the asymptomatic athlete (C) was 30.6 kPa [29.3-32.2] and in the athlete with patellar tendinopathy (F) 117.4
kPa [112.3-133.8].
a
b
c
d
f
0
200
(kPa)
e
Fig. 2 Grayscale US and corresponding shear-wave elastograms in an
asymptomatic athlete and an athlete with patellar tendinopathy. a, d
Longitudinal grayscale ultrasound images of the proximal patellar tendon
in an asymptomatic 19-year-old male basketball player (a) and in a 21-
year-old male basketball player with patellar tendinopathy (d). a shows
normal alignment of collagen bundles, whereas d shows disruption of the
normal tendon architecture with hypoechoic areas separating collagen
bundles. b, e Elastograms depicted as an overlay on grayscale images
where user settings defined red as stiff tissues and blue as soft tissues.
Pronounced red areas (indicating increased stiffness) were typically ob-
served in the proximal patellar tendon of participants with patellar
tendinopathy (e), compared to predominantly light blue areas
(representing intermediate elasticity) in asymptomatic athletes (b). Dark
blue areas posterior to the patellar tendon correspond to the relative soft
Hoffa’s fatpad. The small red area at the left border in both b and e
corresponds to the inferior patellar border and was excluded for quanti-
tative analysis. c, f Multiple partially overlapping circular regions of in-
terest were placed for quantitative analysis of tendon stiffness, covering
the proximal 20 mm of the patellar tendon (referred by reference ruler),
starting 5 mm distal to the inferior patellar pole. The median stiffness
(interquartile range) of the proximal patellar tendon in the asymptomatic
athlete (c) was 30.6 kPa (29.3–32.2) and in the athlete with patellar
tendinopathy (f) 117.4 kPa (112.3–133.8)
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Interobserver reproducibility of SWE
For the interobserver reproducibility, 56 paired measurements
in 28 healthy athletes were used (Table 5). The ICC between
examiner 1 (S.B.) and examiner 2 (A.V.) was 0.79 (95% CI
0.65–0.88) and CR (CV) was 18 kPa (21%). The mean differ-
ence from Bland-Altman analysis (Fig. 4) was 4.6 kPa (95%
CI 1.9–7.2, p < .001) and the limits of agreement were
−14.8 kPa (lower limit) and 24.0 kPa (upper limit).
Discussion
In this study on the implementation of SWE on the patellar
tendon in jumping athletes with patellar tendinopathy and
activity-matched controls, we found that patellar tendinopathy
was associated with significantly higher patellar tendon stiff-
ness, both in univariate analyses and in adjusted multivariate
analyses. The intraobserver reliability of the SWE analysis
was excellent and the interobserver reliability for independent
SWE acquisitions and analyses was good. This finding of
tendon stiffening in PT provides additional information to
GSUS/PDUS and could lead to improved understanding of
the disease and eventually in altered therapeutic decision-
making, for example, by staging the altered viscoelastic prop-
erties in PT and by monitoring the response to therapeutic
interventions.
The trend of increased stiffness was in accordance with
experiments on patellar tendon specimens that reproduced
the increased state of tissue hydration in PT by using hypo-
tonic solutions [29]. This effect may be explained by “hydrau-
lic stiffening,” which has previously been described in bones
[30]. However, the findings of SWE implementations in PT
by different authors are not only different, but even contradic-
tory: both increased [14, 31] and decreased stiffness [32, 33]
in PT have been reported.
Inconsistencies in those studies included methods of image
analysis, different ultrasound equipment, and different
Table 3 The association between
patellar tendon stiffness and
patellar tendinopathy
Determinant Univariable Multivariablea
Age at T0 1.226 (1.114–1.350) 1.407 (0.924–2.144)
Male sex 3.412 (1.683–6.916) 5.663 (0.090–355.276)
Index knee: left 1.111 (0.580–2.128)
Body mass index at T0 1.533 (1.268–1.853) 2.380 (1.554–3.642)
Subcutaneous tissue (mm) 0.545 (0.373–0.795) 0.365 (0.152–0.877)
Cincinnati Sports Activity Scale 0.985 (0.937–1.035)
Patellar tendon stiffness (kPa) 1.094 (1.061–1.128) 1.294 (1.044–1.605)b
Age*stiffness 1.004 (1.003–1.006) 0.994 (0.986–1.003)
Sex*stiffness 1.034 (1.022–1.046) 0.967 (0.890–1.049)
Data are presented as odds ratio (95% CI); data with p < .05 are italicized in univariable model
a Determinants with p < .10 by univariable logistic regression were used in the multivariable model
b Odds ratio for patellar tendon stiffness assessed with shear-wave elastography is estimated for each kilopascal
(kPa)
Table 4 Intraobserver reliability analysis of patellar tendon stiffness in seventy-six athletes with patellar tendinopathy (N = 76 tendons)
Analysis 1 (SB) Analysis 2 (SB) Intraobserver reliability
Location Stiffness (kPa) Stiffness (kPa) CV (%)a CR (kPa)b ICC (95%CI)c
All ROIs 74.9 [56.4–105.4] 69.9 [54.7–100.3] 10.3 (7.9–12.2) 11.9 [5.1–24.9] 0.95 (0.92–0.97)
ROI 1 78.3 [51.6–117.3] 78.4 [51.7–111.6] 15.8 (9.2–20.3) 14.8 [5.3–26.8] 0.92 (0.88–0.95)
ROI 2 85.4 [55.9–127.6] 72.4 [54.4–111.8] 15.1 (12.3–17.4) 16.2 [7.0–44.4] 0.89 (0.83–0.93)
ROI 3 69.7 [52.7–102.3] 63.8 [49.2–84.5] 19.2 (13.3–23.6) 20.2 [6.8–41.6] 0.85 (0.77–0.90)
ROI 4 59.9 [41.7–76.3] 48.9 [34.1–61.9] 18.9 (11.2–24.3) 13.3 [5.5–24.3] 0.92 (0.85–0.95)
Patellar tendon stiffness was assessed using shear-wave elastography (SWE), expressed as median (interquartile range) in kPa
a CV: coefficient-of-variation (%), 95% confidence interval
b CR: coefficient-of-repeatability (kPa), also referred to as the smallest real difference (SRD)
c ICC: intraclass correlation coefficient (ICC), 95% confidence interval
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positioning of the knee. These inconsistencies form potential
explanations for the discordant SWE results [15]. First, the
effect of knee positioning on SWE outcome has been studied
by several authors in which the same trend of increased stiff-
ening in more flexed positions of the knee was found [34, 35].
In passive extension of the knee, we produced less physiolog-
ical tensile stress on the patellar tendon which enabled to
depict better contrasts in the acquired elastograms, whereas
in 30 degrees of flexion, the tensile stress was much larger,
which complicated the SWE acquisition. Therefore, standard-
ized positioning of the knee is regarded as an important factor
to enhance comparability of results [36]. Second, image anal-
ysis varied in other studies from a very small single ROI
(1 mm diameter) in representative locations of the patellar
tendon to a single ROI with flexible diameters centered in
the hypoechoic region of the proximal patellar tendon [14,
33]. We evaluated average stiffness over the proximal patellar
tendon as we assumed that pathological intratendinous chang-
es are diffuse, similar to histologic findings of tissue surround-
ing a tendinotic lesion in Achilles tendinopathy [37, 38].
Moreover, our fixed region of interest facilitated the compar-
ison of tendon stiffness with controls. Third, shear-wave ve-
locities obtained with different US equipment can vary, even
between different transducers and different acquisition depths
[39].
Other differences of our study compared with previous
studies were [1] the extensive inclusion protocol to verify
the eligibility of participants, including a comprehensive
physical examination with ultrasonographic confirmation as
the reference standard, and [2] the assessment of intraobserver
and interobserver reproducibility of SWE, which has not been
reported in studies with comparable sample size.
Nevertheless, the intraobserver and interobserver reliability
we found were comparable with other studies using smaller
sample sizes [34, 40].
Strengths of our study are the relatively large sample size
and homogeneity of the study population with respect to age
and level of sports. Due to our stringent inclusion criteria, the
study population represented the predefined target group
consisting of athletes performing sports involving frequent
Fig. 3 Intraobserver reliability of
SWE in seventy-six athletes with
patellar tendinopathy. Bland-
Altman plot illustrating the
intraobserver reliability for the
patellar tendon stiffness assess-
ment using SWE. The differences
between each pair of the stiffness
measurements plotted on the y-
axis are shown against the mean
of these measurements on the x-
axis. The solid line represents the
mean value and dashed lines rep-
resent the limits of agreement,
defined as mean ± 1.96SD
Table 5 Interobserver reliability
analysis of patellar tendon
stiffness in twenty-eight healthy
athletes (n = 56 tendons)
Examiner 1 (SB) Examiner 2 (AV) Interobserver reliability
Location Stiffness (kPa) Stiffness (kPa) CV (%)a CR (kPa)b ICC (95%CI)c
All ROIs 35.7 [29.2–43.6] 30.4 [24.8–38.9] 21.0 (17.5–24.0) 18.0 [6.2–23.6] 0.79 (0.65–0.88)
ROI 1 31.4 [26.5–41.2] 28.3 [23.1–39.4] 30.2 (23.8–35.4) 19.9 [9.6–29.3] 0.64 (0.39–0.79)
ROI 2 36.2 [27.6–47.2] 49.4 [24.7–38.4] 29.7 (23.9–34.6) 14.3 [9.9–35.3] 0.74 (0.56–0.85)
ROI 3 35.3 [29.8–49.1] 31.1 [23.9–39.9] 33.4 (26.8–38.8) 14.9 [7.7–23.7] 0.66 (0.42–0.80)
ROI 4 37.1 [29.6–45.7] 30.9 [22.3–40.6] 41.8 (35.1–47.6) 16.2 [7.8–25.2] 0.51 (0.15–0.72)
Patellar tendon stiffness was assessed using shear-wave elastography (SWE), expressed as median (interquartile
range) in kPa
a CV: coefficient-of-variation (%), 95% confidence interval
b CR: coefficient-of-repeatability (kPa), also referred to as the smallest real difference (SRD)
c ICC: intraclass correlation coefficient (ICC), 95% confidence interval
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jumping and cutting in which PT is most prevalent. We also
excluded other causes for anterior knee pain than PT such as
patellofemoral pain. Patellofemoral pain is difficult to distin-
guish from PT without focused physical examination [20]
which has led to a substantial amount of exclusions after phys-
ical examination in our study (12% of athletes who were po-
tentially eligible after online screening). Inadequate sampling
methods for athletes with anterior knee pain can potentially
affect results of tendon stiffness.
The main limitation of our study is the known clinical
status of the athletes before the SWE acquisition was
performed, because GSUS and PDUS were part of our
initial eligibility assessment in PT athletes. A second lim-
itation is the difference in baseline characteristics be-
tween PT athletes and controls, despite the relative small
differences of age and anthropometric characteristics.
Therefore, we interpreted the clinical relevance of these
differences as minimal. Third, the intraobserver reliability
was based on analysis of multiple elastograms from one
acquisition in PT athletes and interobserver reliability
was based on a subset of healthy controls, where both
SWE acquisitions and image analyses were performed
by independent examiners.
Future research directions would comprise implementation
of SWE before any reference standard is performed using
standardized acquisition protocols, assessment of the prognos-
tic value of patellar tendon stiffness in longitudinal studies,
and its role to monitor therapy response.
In conclusion, SWE is able to detect higher stiffness of the
proximal patellar tendon in athletes with patellar tendinopathy
with a good to excellent reliability, and could provide attrac-
tive novel biomarkers to assess therapy response.
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Fig. 4 Interobserver reliability of
bilateral SWE in twenty-eight
healthy athletes. Bland-Altman
plot illustrating the interobserver
reliability for the patellar tendon
stiffness assessment using SWE.
The differences between each pair
of the two examiners’ stiffness
measurements plotted on the y-
axis are shown against the mean
of these measurements on the x-
axis. The solid line represents the
mean value and dashed lines rep-
resent the limits of agreement,
defined as mean ± 1.96SD
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